KBRA Assigns Ratings to Pagaya's Latest ABS, but Economic Proof Still Awaited

What happened

KBRA assigned preliminary ratings to Pagaya's PAID 2026-2 ABS transaction, marking another routine securitization deal in the company's capital markets cadence. This follows recent upsized prints like PAID 2026-1, which the DeepValue report notes demonstrated broad investor demand but came with negative capital markets execution fees, signaling underlying spread pressure. The report emphasizes that Pagaya's investment thesis hinges on converting ABS access into positive unit economics, not just issuance volume, with management quantifying that a 100 bps discount in ABS pricing reduces upfront fees by ~$10M. Critical for investors, this announcement lacks details on pricing or execution fees, making it insufficient to assess whether the deal improves profitability amidst credit reserve builds and risk retention costs. Therefore, while funding access persists, the core wait-and-see stance remains until observable proof of economic recovery emerges in upcoming disclosures.

Implication

This new ABS transaction reinforces Pagaya's ability to maintain capital markets access, supporting network volume growth and aligning with the base case for continued issuance. However, the DeepValue report cautions that negative execution fees in recent quarters indicate spread pressure, which could compress upfront fees and hinder EBITDA targets. Investors must monitor the next quarterly filing for capital markets execution fees to turn positive, a key checkpoint highlighted in the report's 90-day monitoring. If credit reserves stabilize and investor breadth holds near 30+ accounts, this could justify moving toward the $13 base case implied value. Conversely, if economics fail to improve, downside risks toward $7 persist due to funding cost shocks and capital strain, underscoring the need for patience before any position adjustment.

Thesis delta

No significant shift in the investment thesis; the 'WAIT' rating remains appropriate as this news confirms ongoing ABS issuance but does not provide evidence of improved unit economics. The thesis still requires observing positive capital markets execution fees and stable allowance for credit losses in the next quarterly report to consider upgrading the call. This event reinforces the critical need to look beyond deal announcements and focus on profitability metrics, as highlighted in the DeepValue report's monitoring points.